Darren W. Begley - Concepedia

Author

Darren W. Begley

Center for Infectious Disease Research

Also Known As

D. Begley, D. W. Begley, Darren Begley, Darren W Begley, Darren W. Begley

Publications

644

Citations

H-Index

Concepts

All Affiliations

Center for Infectious Disease Research University of Washington Joint Center for Structural Genomics Beryllium (United States)University of Washington Medical Center

About

Darren W. Begley is an author at Center for Infectious Disease Research specializing in natural sciences, medicine, and molecular biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	12	13	455
2	Natural Sciences	12	12	327
3	Biochemistry	8	8	208
4	Chemical Biology	5	5	101
5	Biomolecular Engineering	2	2	35

Darren W. Begley

Publications

612

Citations

H-Index

Page 1

	Year	Citations
Increasing the structural coverage of tuberculosis drug targets Loren Baugh, Isabelle Phan, Darren W. Begley, Tuberculosis Pulmonary TuberculosisDrug TargetStructural CoverageMedicineTuberculosis Prevention	2014	128
Combining Functional and Structural Genomics to Sample the Essential Burkholderia Structome Loren Baugh, Larry A. Gallagher, Rapatbhorn Patrapuvich, PLoS ONE	2013	128
Structural genomics of infectious disease drug targets: the SSGCID Robin Stacy, Darren W. Begley, Isabelle Phan, Acta Crystallographica Section F Structural Biology and Crystallization Communications Drug TargetSsgcid PipelineStructural BioinformaticsBiomolecular Structure PredictionProtein Folding	2011	74
A Small-Molecule Probe Induces a Conformation in HIV TAR RNA Capable of Binding Drug-Like Fragments Amy Davidson, Darren W. Begley, Carmen Lau, Journal of Molecular Biology Binding Drug-like FragmentsViral ReplicationBiochemistryProtein FoldingNatural Sciences	2011	59
Multivalent Drug Design and Inhibition of Cholera Toxin by Specific and Transient Protein–Ligand Interactions Jiyun Liu, Darren W. Begley, Daniel D. Mitchell, Chemical Biology & Drug Design Molecular DockingMolecular RecognitionMedicinal ChemistryMultivalent Drug DesignMultivalent Inhibitors	2008	30
Mycofactocin-associated mycobacterial dehydrogenases with non-exchangeable NAD cofactors Daniel H. Haft, Phillip G. Pierce, Stephen J. Mayclin, Scientific Reports Pulmonary TuberculosisBiochemistryNatural SciencesMycobacterium TuberculosisMolecular Biology	2017	26
A Structural Biology Approach Enables the Development of Antimicrobials Targeting Bacterial Immunophilins Darren W. Begley, David Fox, Dominic C. Jenner, Antimicrobial Agents and Chemotherapy Crystal StructureBacteriophageMolecular BiologyStructural Biology ApproachChemical Biology	2013	22
Leveraging structure determination with fragment screening for infectious disease drug targets: MECP synthase from Burkholderia pseudomallei Darren W. Begley, Robert C. Hartley, D.R. Davies, Journal of Structural and Functional Genomics Drug TargetBioorganic ChemistryStructural BioinformaticsBiomolecular Structure PredictionMolecular Biology	2011	20
Saturation Transfer Difference NMR for Fragment Screening Darren W. Begley, Spencer O. Moen, Phillip G. Pierce, Current Protocols in Chemical Biology	2013	18
Inhibitor-bound complexes of dihydrofolate reductase-thymidylate synthase from<i>Babesia bovis</i> Darren W. Begley, Thomas E. Edwards, Amy Raymond, Acta Crystallographica Section F Structural Biology and Crystallization Communications BiosynthesisBioorganic ChemistryCellular EnzymologyBiochemistryAntiparasitic Agent	2011	18

Page 1